Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines.
about
POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillanceEndometrial cancer gene panels: clinical diagnostic vs research germline DNA testing.The Rising Incidence of Younger Patients With Colorectal Cancer: Questions About Screening, Biology, and Treatment.Population-based screening for cancer: hope and hype.Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group StudyLynch syndrome-related small intestinal adenocarcinomas.Novel mutations and phenotypic associations identified through APC, MUTYH, NTHL1, POLD1, POLE gene analysis in Indian Familial Adenomatous Polyposis cohortAchieving behaviour change for detection of Lynch syndrome using the Theoretical Domains Framework Implementation (TDFI) approach: a study protocolSporadic colorectal cancer: Studying ways to an end.Hereditary cancer syndromes: utilizing DNA repair deficiency as therapeutic targetReflex test reminders in required cancer synoptic templates decrease order entry error: An analysis of mismatch repair immunohistochemical orders to screen for Lynch syndrome.Management strategies in Lynch syndrome and familial adenomatous polyposis: a national healthcare survey in Japan.Molecular genetics of microsatellite-unstable colorectal cancer for pathologists.Risk of subsequent primary malignancies among patients with prior colorectal cancer: a population-based cohort study.Lynch syndrome: five unanswered questions.Using Genetics to Identify Hereditary Colorectal Polyposis and Cancer Syndromes in Your Patient.Systematic Review of Hospital Based Cancer Registries (HBCRs): Necessary Tool to Improve Quality of Care in Cancer PatientsA model for patient-direct screening and referral for familial cancer risk.Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.An Individual with Both MUTYH-Associated Polyposis and Lynch Syndrome Identified by Multi-Gene Hereditary Cancer Panel Testing: A Case Report.Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group StudyPersonalised Medicine Approaches to Screening and Prevention.Mutant-Allele Tumor Heterogeneity Scores Correlate With Risk of Metastases in Colon Cancer.Is there a role for prophylactic colectomy in Lynch syndrome patients with inflammatory bowel disease?High frequency of mismatch repair deficiency among pediatric high grade gliomas in Jordan.Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohorts.DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics.Barriers and Facilitating Factors for Implementation of Genetic Services: A Public Health Perspective.A Systematic Review on the Existing Screening Pathways for Lynch Syndrome Identification.Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival.The Optimal Cut-Off Level of The Fecal Immunochemical Test For Colorectal Cancer Screening in a Country with Limited Colonoscopy Resources: A Multi-Center Study from ThailandDisease Biomarkers in Gastrointestinal Malignancies.The Brazilian Hereditary Cancer Network: historical aspects and challenges for clinical cancer genetics in the public health care system in Brazil.Impact of Fecal Hb Levels on Advanced Neoplasia Detection and the Diagnostic Miss Rate For Colorectal Cancer Screening in High-Risk vs. Average-Risk Subjects: a Multi-Center Study.Including Lynch syndrome in personalized prognostication and follow-up of stage II and III colon cancer.Validation of Immunohistochemical Assays for Integral Biomarkers in the NCI-MATCH EAY131 Clinical Trial.Evaluation of an online family history tool for identifying hereditary and familial colorectal cancer.Germline mutations in patients with multiple colorectal polyps in China.Reply to the letter to the editor 'Including lynch syndrome in personalized prognostication and follow-up of stage II and III colon cancer' by Sciallero et al.Evolving notions on immune response in colorectal cancer and their implications for biomarker development.
P2860
Q28264404-AC542A7D-3F27-4F69-872D-808E876F1852Q30234614-14C71D46-3511-4881-A6FA-AD6C48584CF1Q30234889-C63B56D4-C612-4CF0-9534-379D0C934CC6Q30251601-90193231-3143-415E-8FC8-58C3D6D46282Q30361978-D5F5320E-9B5C-4840-9F17-112F2AAEEAA9Q33591577-990C7B9F-C0CA-4E34-8CB7-B07D6EF61376Q33714866-ED25595E-89EC-41EB-9969-D97C6F37A7A0Q35954744-5B728DD4-E769-4F58-95C4-E804B1168272Q36719832-F50A93AA-724D-4175-B01E-4DF26BEB1C2CQ36990060-B9398B25-0FA1-42AA-A547-F79AF84AB35EQ37477005-A8A96762-F931-4CFD-8BAE-FC6B46858A73Q37670683-127005F5-37E2-47A6-9557-E4E6F8DA0327Q37680161-86E8DAE6-98B0-45B5-9D35-69046C07346AQ37712344-AD231AFD-4706-45FE-A040-BFE58BF7ADF8Q38367449-875E6BAC-A4C3-4F63-B325-DCE65948DBD8Q38570349-2F77E1E9-31F8-40DB-BC4D-82451F773AEFQ38607309-92A242F2-BF69-47C1-9DFF-245AAD0D5A5FQ38879087-1FF9FA6D-117E-449F-8921-6BB73155D8F3Q38979257-BCE689AA-809B-4B13-ABE4-FADB6F90B444Q39020597-99EEBDE6-494C-4F3A-B6F8-88884D2A47A8Q39668107-744EF697-EC65-4A09-AB41-17EAEF8D8806Q40197199-93B35E67-59EB-430E-A152-436E41B8FA09Q40386896-D72ED370-F32A-423E-9969-41753E141299Q40494096-55E038A4-F5A1-4E2F-8A35-4F327D5B671AQ40622084-098E49D3-A129-4115-A10F-7CA151DF1671Q40713486-44C50D90-C1E7-41C0-A642-2FA5575387FEQ41024077-1E449C0C-FD35-4B69-8040-1C6C1AA4685AQ41243055-08705FCF-818E-4693-A39A-41BCBA3AA944Q41684878-FDDC51E9-35A1-4AFE-8E95-DBB9ED85E6A8Q41726020-73A799E4-D121-43A5-A057-B16D51F416D7Q42143973-DEB8457E-3816-41A6-AE4C-B6461EC35284Q42416485-1F1B9A2A-0A4A-47A8-A5AD-0F05DBF60AA0Q42699063-EAA12264-991F-4B74-B7BE-3DDB774B7245Q47137106-A62566D5-9E6F-4CD3-A79C-09EEF403ADACQ47636379-512B0B40-D1C0-4F49-8C05-4210846BEFB5Q47908752-6D6F9F68-EF89-46DA-91D5-C5174C24C8CDQ48653777-301324B2-E5E8-44F6-90B6-9E7164C3F34CQ48818506-F2E43C93-FECC-4501-A88A-EA38DF562368Q50089378-D0B8FFC6-F18C-4BF7-9360-5D2F368E9635Q50098505-DBD02E1E-DC92-4ED6-A2F4-F5408AFE1E3C
P2860
Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hereditary colorectal cancer s ...... Clinical Practice Guidelines.
@en
Hereditary colorectal cancer s ...... Clinical Practice Guidelines.
@nl
type
label
Hereditary colorectal cancer s ...... Clinical Practice Guidelines.
@en
Hereditary colorectal cancer s ...... Clinical Practice Guidelines.
@nl
prefLabel
Hereditary colorectal cancer s ...... Clinical Practice Guidelines.
@en
Hereditary colorectal cancer s ...... Clinical Practice Guidelines.
@nl
P2093
P2860
P356
P1476
Hereditary colorectal cancer s ...... Clinical Practice Guidelines.
@en
P2093
Elena M Stoffel
European Society of Clinical Oncology
Karen H Lu
Matthew F Kalady
Michelle Wan Yee Lau
Nancy Roach
Pamela B Mangu
Paul J Limburg
Stanley R Hamilton
Stephen B Gruber
P2860
P304
P356
10.1200/JCO.2014.58.1322
P407
P577
2014-12-01T00:00:00Z